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Summary
Thioredoxin 1 (Trx1) is a key redox modulator that is functionally conserved across a wide range of species, including plants, bacteria and mammals. Using a conserved CXXC motif, Trx1 catalyzes the reduction of cysteine disulfides and S-nitrosothiols. In contrast to small molecular reductants such as glutathione and cysteine that can reduce a wide range of oxidized proteins, Trx1 reduces only selected proteins via specific protein-protein interaction. Trx1 has been shown to regulate a wide range of signal transduction pathways, and its dysfunctions have been implicated in several diseases, including cancer, inflammation, and neurodegenerative and cardiovascular diseases. Identification of Trx1 target proteins may help to identify novel signaling mechanisms that are important for Trx1 anti-stress responses. In this study, we performed an isotope-coded affinity tag (ICAT) proteomic study for the identification of Trx1 target proteins from the hearts of a cardiac-specific Trx1-overexpressing transgenic mouse model (Tg-Trx1). Trx1-reduced proteins were distinguished from Trx1-induced proteins by comparison of the ICAT results with those obtained using a parallel isobaric tags for relative and absolute quantitation (iTRAQ) protein expression analysis. We were able to identify 78 putative Trx1 reductive sites in 55 proteins. Interestingly, we have identified a few protein functional networks that had not previously been shown to be regulated by Trx1, including the creatinephosphocreatine shuttle, the mitochondrial permeability transition pore complex, and the cardiac contractile apparatus. The results presented here suggest that in addition to a general antioxidant function, Trx1 may be involved in the coordination of a wide array of cellular functions for maintaining proper cardiac energy dynamics and facilitating muscle contraction.
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Introduction:
Thioredoxins (Trx) are a class of antioxidant proteins that mediate the reduction of specific disulfide bonds and S-nitrosothiols within oxidized proteins. Trx, together with the NADPHdependent thioredoxin reductase (TrxR), form a protein reductive system that plays essential roles in the clearance of elevated reactive oxygen species (ROS), the repair of oxidatively modified proteins, and the restoration of cellular redox homeostasis. Two isoforms of Trx have been widely studied: Trx1 is mostly found in the cytosol and nucleus, while Trx2 is mitochondrion-specific. Each Trx isoform is coupled with its own TrxR systems. Trx1 has been shown to promote cell growth, proliferation, and inhibit apoptosis by modulating both caspasedependent and -independent pathways. Trx1 has also been demonstrated to be a potent regulator of a wide variety of transcription factors and other gene expression regulators by preserving the reductive states of specific cysteines within transiently oxidized proteins such as nuclear factor κB (1), hypoxia inducible factor (HIF)-1α (2), histone deacetylase 4 (HDAC4) (3), and glucocorticoid receptor (4) . A wide range of bioanalytical techniques have been applied to identify Trx1 targets, including 2DE-based differential thiol labeling (5, 6) , Trx affinity chromatography (7, 8) and ICAT (9) . ICAT technique is of particular interest to redox analysis due to its capability to aid the identification of potential reduction sites within substrate proteins as well as the quantification of the extent of reduction (10) . This technique was pioneered by Aebersold et al. for the quantification of proteins by isotope-tagging of cysteines. The advantage of this technique resides within its ability for the enrichment of cysteine-containing peptides for the reduction of sample complexity, resulting in more depth in stable isotope-based quantitative proteome coverage than conventional shotgun proteomic methods (11) . Cohen group has tailored this technique to probe the redox status of protein cysteines and identified redox-sensitive by on May 15, 2009 www.mcponline.org Downloaded from cysteines in cardiac sarcoplasmic reticulum proteins including ion channels that may be important for modulating cardiac functions (12, 13) . Furthermore, they have also elegantly mapped differential cysteine thiols redox-sensitivities of p21ras GTPase towards peroxynitrite and oxidized glutathione (14) . More recently, Svensson and coworkers have used a modified ICAT method to discover over 100 in vitro Trx reduction targets in plants (9) , in which Trxinduced changes in protein disulfides were quantified. This report has provided the largest number of Trx-targeting plant disulfides to date, demonstrating the feasibility of using this technique for uncovering Trx targets in mammalian systems. In this study, we have adopted a redox ICAT strategy to detect potential Trx1 reduction targets in rodent tissues.
Trx1 has been associated with a wide variety of diseases with oxidative imbalance, including cancer (15) , HIV infection (16), neurodegenerative diseases (17) and cardiovascular diseases (18) . We were interested in understanding the roles of Trx1 in the protection of heart function in a rodent model of cardiac hypertrophy, the adaptive enlargement of the heart when under stress.
However, prolonged pathological hypertrophy has been associated with metabolic disorder, inadequate ATP supply, contractile dysfunction, and gradual development into heart failure (19) .
We have previously shown that overexpression of Trx1 (in Tg-Trx1 animals) plays a central role in the activation of cardioprotective signal transduction pathways within hypertrophic hearts (3, 20) . Mechanistically, Trx1 may also exert its function through the regulation of gene expression, translation and post-translational modifications (PTMs). In a previous RNA microarray study (21), we reported that a wide range of genes are significantly altered in the hearts of Tg-Trx1 mice, including the up-regulation of genes involved in oxidative phosphorylation, tricarboxylic acid (TCA) cycle, and several stress-related transcriptional factors. Given its known function as a protein reductant, a significant aspect of Trx1 function is expected to be exerted through the by on May 15, 2009 www.mcponline.org Downloaded from selective reduction of target proteins. For example, we have recently reported that HDAC4 is an important target of Trx1 reduction in heart (3). Trx1 facilitates the formation of an HDAC4-containing multi-protein complex resulting in HDAC4 nuclear translocation, and thus regulates the expression of anti-hypertrophic genes. It is likely that in addition to regulating the function of individual proteins, Trx1 may also exert its cardiac protective function by coordinately regulating a series of protein networks. To identify such protein networks, we conducted an ICAT-based proteomics study to identify proteins whose cysteine thiols became more reduced in the hearts of Tg-Trx1 animals over the control animals. The ICAT results were compared with data obtained from the iTRAQ-based protein expression analysis to reveal genuine Trx1-reduction protein targets, as opposed to Trx1-induced proteins. We discovered that protein networks associated with energy production and utilization processes, such as glycolysis, TCA cycle, β-oxidation, mitochondrial permeability transition pore (MPTP) complex, and the contractile apparatus of the myofibrils, were affected by Trx1 overexpression, suggesting a role for Trx1 in maintaining heart energetics.
Materials and Methods
Chemicals and reagents
HPLC grade acetonitrile (ACN) and water were purchased from J. T. Baker (Phillipsburg, NJ, USA). Sequencing grade modified-trypsin was from Promega (Madison, WI). Tris, α-cyano-4-hydroxycinnamic acid (CHCA), catalase, protease inhibitor cocktail (P8340), and other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless stated otherwise. 
Transgenic mouse generation and transverse aortic constriction (TAC) surgery
Mice with cardiac-specific overexpression of Trx1 (Tg-Trx1) were generated on an FVB background, using the α-myosin heavy chain promoter as described previously (21, 22).
Induction of cardiac hypertrophy was accomplished by surgical constriction of the transverse thoracic aorta and was performed on both the control and Tg-Trx1 mice as reported earlier (23) .
Briefly, mice were anesthetized with pentobarbital sodium solution (60 mg/kg, i.p.) and ventilated using a rodent ventilator. The left chest was entered through the second intercostal space and the aorta was isolated. A prolene suture was placed around the aorta between the innominate artery and the left carotid artery. A 27-gauge needle was tied onto the aorta and later removed. The chest was then closed in layers. The animals were kept warm and the rectal temperature was maintained at 37 °C. After weaning from the ventilator, the mice were kept in an incubator with humidified oxygen, and returned to cages after recovering from anesthesia. All protocols regarding the use of animals were in compliance with the regulations of the Institutional Animal Care and Use Committee at UMDNJ.
Protein extraction
Protein extracts were prepared from ~100 mg of diced left ventricular tissues after three cold phosphate buffered saline (PBS) washes and were homogenized with a tissue homogenizer (Omni International, Marittta, GA) in 500 μl lysis buffer. For the ICAT proteomics study, 6 
ICAT labeling and multidimensional chromatography
The ICAT labeling procedures used for this study have been described previously (10) and illustrated in Fig. 1 . In brief, 100 μg of each of the three independent control extracts was labeled with the light ICAT reagents, and the same amounts of Tg-Trx1 samples (3 animals) were labeled with the heavy ICAT reagents at 37 o C for 2 hr. No reduction and alkylation steps were performed prior to ICAT labeling to preserve the native protein thiol redox states. Excess ICAT reagents were removed with the addition of 50 mM DTT. Newly generated free thiols were alkylated with 50 mM iodoacetamide (IAA). The light (L) and heavy (H) ICAT-labeled proteins were mixed and subjected to tryptic digestions at a 50:1 protein/enzyme ratio. Tryptic digested peptides were acidified and fractionated using strong cation exchange chromatography (SCX (Fig. 1) . The iTRAQ-labeled peptides were first combined, and dried in a speedvac and were then resuspended in 500 μl Buffer A, which contained 10 mM KH 2 PO 4 and 20% ACN (pH 2.7),
and was subjected to a SCX fractionation using a polysulfoethyl A column Trx1-reduced DJ-1 was then labeled with the ICAT-H reagent, and the buffer-treated control was labeled with the ICAT-L reagent. The remaining procedures followed the ICAT protocols described above, except that the SCX step was carried out with a SCX cartridge provided in the ICAT labeling kit (ABI), according to the manufacturer's protocol.
MS and database search
A) ICAT: RPLC-purified peptides were analyzed on a 4800 MALDI-TOF/TOF mass spectrometer (ABI) operating in the reflectron mode. First, 2,000 shots were accumulated for by on May 15, 2009 www.mcponline.org
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each MS spectrum with a mass range m/z 800 -3,800. Internal calibration standards were used for achieving a mass accuracy better than 50 ppm. Following MS analysis, the isotope ion cluster intensities of ICAT pair ions (heavy and light ions with a mass difference of 9.03 ± 0.03 Da)
were extracted and quantified from the parent spectra with the GPS Explorer software (v3.5, ABI). Only ICAT pairs with at least 20% intensity differences and S/N over 50 were submitted for MS/MS analysis, 3,500 shots were accumulated for each MS/MS spectrum. The peak-lists were generated with 4000 Series Explorer (v 3.5, ABI). For peak detection, a signal-to-noise ratio (S/N) threshold was set to 10, local noise window width was 250 m/z and minimum peak width bin size was 2.9; resolution was set at 22,000 at m/z 2,400 for MS and 8,000 at m/z 2,000
for identifications. Each MS/MS spectrum was subjected to manual inspection for the confirmation of positive identifications. False discovery rates were estimated to be less than 4% for all three experiments (calculation according to Peng et al. (24) ). Typical ICAT quantification accuracy with this workflow on our instruments was evaluated by using BSA tryptic peptides of set mixing ratios. The analytical CV values of less than 10% was observed (10) . For the data presented in Table 1 , we decided to include only peptides with ICAT changes beyond 20% of the population median, so that future biological validations are more likely to be successful. I. values no less than 95% were used for protein identification and quantitation. Protein expression ratios (Tg-Trx1/Control) were calculated as described previously (25, 26) . Briefly, the iTRAQ reporter ion cluster areas were extracted using the GPS Explorer software (ABI), and only ion counts more than 5,000 were used for quantification analysis. The individual report ion peak areas for each iTRAQ channel were normalized by the population median. For confident protein identification (average of at least 2 unique peptides per protein), relative protein expression ratio distribution and the standard deviations between the animal groups were determined accordingly. In this study, 2 biological replicates of the iTRAQ-labeled sample were analyzed and a student's t-test was performed to determine differentially expressed proteins. Proteins quantified with p values no more than 0.05 and a protein expression ratio beyond 20% of population median were considered as differentially expressed (26) . 
ANT1 immunoprecipitation and Western blotting
Heart proteins were extracted with a buffer containing 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton-X100, 1 mM sodium orthovanadate, 2. 
Statistical analyses
ICAT data are expressed as ICAT pair ratios (H/L: Tg-Trx1/control) from three independent experiments ( 
Trx1 reductive target sequence motif search
An iterative statistical program (27) , motif-x (http://motif-x.med.harvard.edu/), was used to extract potential Trx1 reductive motifs among the identified target sequences. Cysteine was assigned as the centralized amino acid, and foreground sequences was extended to 15 amino acids on each side of the cysteine. Significance threshold was set at 0.000001.
Results
Identification of putative Trx1 target cysteines in cardiac proteins
Hypertrophy and increased oxidative stress in hearts were introduced with TAC surgery in both control and Tg-Trx1 mice. Western analysis confirmed the significant upregulation of Trx1 in transgenic animals (Supplemental Fig. 1 ). TAC induced a significant increase in left ventricle weight (LVW) / body weight (BW, 4.0 ± 0.2 mg/g), an index of cardiac hypertrophy in control mice, whereas the increases in LVW/BW were significantly attenuated in Tg-Trx1 mice (3.5 ± 0.1 mg/g, p < 0.01), consistent with our previous observation (22) . Both Tg-Trx1 and control animals, when subjected to TAC surgery, incurred elevated oxidation of many proteins (21, 22).
However, the elevated Trx1 levels in the transgenic mice facilitate the reduction of specific cysteines in target proteins. We employed a forward ICAT labeling strategy as previously described (10) to identify redox-sensitive cysteines that are putative targets of Trx1 in TACstressed mouse hearts (Fig.1) . ICAT-H reagent was used to label Tg-Trx1 samples, while the ICAT-L reagent was used to label the control samples. In such a scheme, Trx1-induced protein thiol reduction would be manifested as H/L ratios larger than 1.0. Within three independent ICAT experiments, we observed ~ 2,000 ICAT ion pairs with a mean ICAT ratio of 1.15 (ICAT ratios presented in unique peptides with C. I. value ≥95% in the three experiments (Supplemental Table 1 ).
According to our previous analysis of ICAT redox proteomics workflow on our MS instrument (10), typical quantification CV is less than 10%. Therefore, a more stringent 20% ICAT quantification ratio was used as a cutoff value for determining significant reduction of protein thiol levels between control and Tg-Trx1 animals. Only peptides fulfilled the following criteria were included in Table 1 , i) C.I. value ≥ 95%, ii) identified in all three ICAT experiments, iii) p value ≤ 0.05, iv) ICAT ratios changes beyond 20% of the population median.
We found that 78 cysteines within 55 proteins were significantly reduced by Trx1 overexpression in all three experiments ( Table 1 , categorized by gene ontology (GO) functional groups), and an additional 70 peptides in at least two experiments (Supplemental Table 1 ).
Potential Trx1 target proteins demonstrated various degrees of sensitivity to Trx1 reduction, ranging from a 20 to ~300% increase in free cysteine thiol levels. The majority of the Trx1-responsive proteins included structural proteins, ion channels, stress response proteins, metabolic enzymes in the glycolysis pathway, TCA cycle, oxidative phosphorylation, and β-oxidation of fatty acids.
We previously showed that TAC treatment resulted in increased oxidative stress in heart, likely resulting in elevated protein oxidation (22) . A large number of proteins were found to contain cysteines highly sensitive to Trx1 reduction, including glyceraldehyde- were non-responsive to Trx1 as no significant differences were found between the light and heavy ICAT labeled peptides (Supplemental Table 1 ). Cys90, Cys180 and 317 responded positively to the Trx1-mediated reduction leading to an increase in heavy ICAT-labeled peptides ions by 20%, 60% and 70%, respectively ( Table 1) . Protein levels of creatine kinase were comparable between the control and Tg-Trx1 animals as evidenced by an iTRAQ ratio of 0.9.
To understand whether the observed increase of free thiol content was exclusively due to Trx1- 
Validation of ADP/ATP translocase 1 (ANT1) as a direct Trx1 reduction target
Following the ICAT proteomics study, we confirmed that one of the proteins, ANT1, contained an oxidized cysteine that can be directly reduced by Trx1 (Fig. 2) . First, the fragmentations of a heavy ICAT-labeled peptide (m/z 1432.72) generated an MS/MS ion profile that matched to ANT1 153 EFNGLGDCLTK 163 sequence with a rather complete y-ion series (Fig. 2A) . The MS quantification of the ICAT pair revealed a more than two-fold increase in free thiols in this peptide when comparing Tg-Trx1 animals with wild type animals ( Fig. 2A, insert) . In a parallel iTRAQ experiment, the same peptide was identified with almost complete b-and y-ion series (Fig. 2B) . iTRAQ reporter ions showed that comparable levels of ANT1 were present in both control and Tg-Trx1 samples (Fig. 2B, insert) . By evaluating the ICAT and iTRAQ proteomics results, we concluded that overexpression of Trx1 was capable of reducing the oxidized Cys160 of ANT1. Next, we sought to validate that ANT1 is a genuine target of Trx1 reduction using an alternative approach. Heart proteins were first subjected to H 2 O 2 oxidation, followed by treatment with different reductants including Trx1, Trx1/TrxR/NADPH, and TCEP. The free protein thiols in the treated proteins were labeled with biotin-HPDP, immunoprecipitated with an anti-ANT1 antibody, and then blotted with different antibodies. We observed that ANT1 protein levels were constant across all four samples ( Fig. 2C and E) . Western blot analysis with biotin showed that only trace levels of biotinylated ANT1 (a marker for free thiol levels) was detected in H 2 O 2 -treated samples, indicating that most of the ANT1 cysteines were oxidized (Fig. 2D,   lane 1) . Trx1 treatment led to a ~30% increase in free thiols (Fig. 2D, lane 2) . Treatment of the cell lysate with the Trx1/TrxR/NADPH reduction system increased ~ 130% of protein thiols (Fig.   2D, lane 3) , suggesting that Trx1 regeneration was important to its reduction of ANT1. Lastly, a strong reductant, TCEP, restored ~ 210% of the oxidized cysteines to the reduced states (Fig. 2D (Fig. 2E) . Furthermore, TCEP non-specifically reduced most of the oxidized cysteines, including those that were non-responsive to Trx1.
Trx1 system reversibly reduced Cys53 in DJ-1
In Tg-Trx1 mice, Trx1 restored ~ 60% of the free thiols in the DJ-1 peptide 49 DVMICPDTSLEDAK 62 compared to the control mouse heart (Fig. 3A, insert ). An almost continuous series of y-ions were observed in the MS/MS spectra (Fig. 3A) . A mass difference of 339.1 Da between the y9 and y10 ions corresponded to the addition of a cleaved heavy ICAT label to Cys53. To confirm that the reduction of this specific cysteine was Trx1-dependent, we simulated oxidative stress by treating recombinant human DJ-1 protein with mild H 2 O 2 (200 µM) for 30 min, followed by removal of excess H 2 O 2 with catalase (at a final concentration of 0.1 µg/ml). The oxidized DJ-1 samples were then incubated with either the activated Trx1/TrxR/NADPH system or blank reaction buffer for 20 min at room temperature, and subjected to ICAT labeling. We observed only trace levels of available protein thiols labeled with the light ICAT reagent, however the Trx1/TrxR/NADPH system reduced a significant amount of the oxidized Cys53 in peptide 49 DVVICPDASLEDAK 62 (Fig. 3B, insert) . Although the tryptic peptide sequences are slightly different between mouse and human DJ-1, Cys53 is highly conserved in both species. In conclusion, both in vivo and in vitro experiments confirmed that Cys53 is a redox-sensitive cysteine, and its redox state can be regulated by the Trx1 reduction system.
Identification of potential Trx1 interactive sequence motifs
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We have also examined all the putative Trx1 target sequences found in this study for possible presence of consensus sequence motifs. Interestingly, we discovered 2 potential CxxC motifs (where either one or both cysteines could be reduced by Trx1) resembling the catalytic site of Trx1 (Supplemental Fig. 2) 
Discussion
Heart oxidative stress and Trx1 function
Understanding the components of cellular anti-stress pathways may provide clues on how to develop specific therapeutic agents for stress-related heart diseases. Trx1 and the affiliated redox regulatory system are important mechanism by which cardiac myocytes counter the detrimental effects of oxidative stress. Our earlier studies suggested that Trx1 is protective in cardiac myocytes in animal models of heart diseases, by means of the reduction of specific protein targets (3). In addition, we also observed increased activities among several mitochondrial enzymes and elevated ATP content in Tg-Trx1 hearts (21). In this study, through a comparative ICAT-proteomics study of Tg-Trx1 and control animals, we identified 55 potential Trx1 reduction targets in the heart, including several previously reported Trx1 targets ( which validated our approach. In addition, we discovered novel Trx1 reduction protein networks for maintaining energy conductance from mitochondria to the cardiac contractile apparatus, which will be discussed below (Fig. 4) .
Comparison of ICAT and iTRAQ analysis results
The importance of Trx1 has spurred enormous interest in identifying its targets, an endeavor that has been aided by the developments of innovative techniques such as fluorescent diagonal electrophoresis (5) and affinity chromatography (28, 29) . However, these approaches have not been able to provide quantitative information regarding the degree or the specific sites of reduction; both are critical for relating protein redox status and the associated biological functions. ICAT is a cysteine-specific isotope-labeling method for peptide quantification at the MS levels, while iTRAQ reagents label primary amines for isobaric peptide quantification at the MS/MS levels. Both methods have been widely used for large-scale quantification of proteins (9, 10, 13, 25) . To capture cysteine thiol redox status, the reduction/alkylation steps were omitted for this ICAT analysis. This strategy allowed the detection of the increase of specific protein thiols in Tg-Trx1 animals. The increase of the ICAT ratios could be due to Trx1-mediated gene/protein expression differences, protein reduction, or a combination of these elements. To differentiate these possibilities, we compared the ICAT proteomics results with those obtained from the iTRAQ expression analysis, in which the TCEP reduction/MMTS alkylation steps were done to determine the relative protein expression levels of the same samples. Interestingly, the expression levels of the 55 significant Trx1 reductive targets ( Table 1) were not significantly changed in the iTRAQ study, indicating that the increase in cysteine thiol levels in Trx1 mouse hearts was largely due to Trx1-mediated reduction of redox-sensitive thiols.
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There were also indications of some proteins (peptides) more oxidized in Tg-Trx1 animals (catalase, ICAT ratio 0.48 and ubiquinol-cytochrome-c reductase complex core protein 1, ICAT ratio 0.65, Supplemental Table 1 ). However, these proteins did not satisfy our stringent criteria for target selection (e. g. observed in all three independent experiments). The number of oxidized proteins in Tg-Trx1 animals was relatively small, and was included in the Supplemental Table   1 . We hypothesize that the reason why some proteins were oxidized more significantly in TgTrx1 animals may be due to Trx1-induced activation of oxidoreductases (Ero1α (30), for example) that can in turn oxidize downstream targets.
Validation of Trx1 targets
Many of the proteins revealed from this study have been reported previously to be direct Trx1 reduction targets (Table 1) shown to be prone to oxidation (37, 38) . Oxidation of Cys159 in human ANT1 (corresponding to the conserved Cys160 in mouse), within the binding site of adenine nucleotides, has been shown to be detrimental to pore function and nucleotide transport (38) . In this study, although ANT1 protein levels were comparable for all animals, Cys160 was found to be more reduced in TgTrx1 than wild type hearts (Tg-Trx1/control ratio of 2.5, Table 1 and Fig. 2A and B) . We also found that ANT1 was oxidized by H 2 O 2 (Fig. 2D, lane 1) , and plain Trx1 was able to partially reverse the oxidation of free thiols ( Fig. 2C and D, lane 2) . The reduction effect was more pronounced when TrxR and NADPH were included for Trx1 regeneration ( Fig. 2C and D, lane 3), suggesting that ANT1 could be a direct target of Trx1 reduction. More importantly, Cys160
was likely to be a reactive cysteine within ANT1 that was reduced by Trx1, given that TCEP was more thorough at potentially reducing all oxidized cysteine thiols non-specifically in ANT1 than Trx1 ( Fig. 2C and D, lane 4) . In this study, we also observed other MPTP components were modulated by Trx1, including creatine kinase, VDAC1, and CypD (Supplemental Table 1) suggesting MPTP may be directly regulated by Trx1 in a redox-dependent manner to sustain the supply of ATP for the heart under TAC-induced oxidative stress.
In addition to validating Trx1 targets at the protein levels, we also performed experiments to confirm that such regulation is site-specific. DJ-1 is a redox-sensitive protein associated with the development of Parkinson's disease (39) . Although it is expressed in the heart, its cardiac function is largely unexplored. DJ-1 deficiency in neuronal cells has been shown to sensitize cells to oxidative stress, and may result in cell death (40) ; overexpression of DJ-1 is cytoprotective (41) . There are 4 cysteines in mouse DJ-1, several of which have been shown to be very sensitive to oxidative stress (39, 42) . No reports have shown that Trx1 is able to repair by on May 15, 2009 www.mcponline.org Downloaded from DJ-1 oxidative damages. Our in vitro study showed that Cys53, a highly conserved residue among mammalian species, may be a Trx1 reductive target ( Table 1 and Fig. 3A) , which is significant given previous reports of cysteinylation on Cys53 upon oxidative stress (39) . In a follow-up experiment, we were able to show that Cys53 in human DJ-1 is sensitive to H 2 O 2 oxidation (Fig. 3B) , and its oxidation can be almost completely reduced by direct interaction with Trx1 (Fig. 3B) .
Trx1 targets within energy pathways
Not much is known of the impact of Trx1 on metabolic protein functions in mammalian cells, especially in heart tissues, where the demand for metabolic fuel is high. Typically, when diseased hearts become stressed, they become adaptively hypertrophied, exhibiting significant metabolic dysfunction (43) . For example, the disruption of β-oxidation of fatty acids has been reported in hypertrophied hearts, resulting in both the reduction of acetyl-CoA supply for the TCA cycle and accumulation of toxic lipid derivatives (44) . Deficiency of very-long-chain acylCoA dehydrogenase is known to induce heart hypertrophy (45). Here we found that both longchain and very-long-chain acyl-CoA dehydrogenases are potential Trx1 reduction targets ( Table   1 ), suggesting that within Tg-Trx1 animals, the lipid metabolic profiles may be protected from oxidative stress to maintain proper heart functions (Fig. 4) .
Creatine kinase (CK) plays an important role in shuttling ATP from the mitochondria to myofibrils, supporting robust heart muscle contraction. There are two forms of CKs in cardiomyocytes, cytosolic CK (cCK) and muscular CK (mCK), which work in tandem to transfer the high energy phosphates from ATP to the contractile apparatus (Fig. 4) . Our ICAT analysis identified that both cCK and mCK are potential substrates for Trx1 reduction. Cys317 in the 311 LGYILTCPSNLGTGLR 326 peptide within the catalytic site of cCK has been shown to be sensitive to oxidation, resulting in the inhibition of its enzymatic activity (12, 46) . About 60% more free thiols in this peptide were found in Tg-Trx1, suggesting that Trx1 may help to maintain the CK activity, facilitating energy conductance from mitochondria to the heart contractile machinery.
Oxidation of cardiac contractile proteins has been shown to impair the plasticity and contractility of muscles, and could be reduced by antioxidants in vitro (47, 48) . We observed that a wide spectrum of sarcomeric proteins were reduced by Trx1 overexpression ( Table 1) ,
suggesting Trx1 may play a direct role in maintaining cardiac contractile apparatus functionality and energy utilization (Fig. 4) .
Limitation of the current redox ICAT method
Although the redox ICAT method is effective for finding potential Trx1 target proteins, many well-characterized Trx1 targets such as peroxiredoxin 1 (Prx1), peroxiredoxin 2 (Prx2) and ribonucleotide reductase were missing from this study. analysis, but may be relatively low in abundance to be detected; 3) some peptides with significant ICAT ratio changes in MS levels, but their MS/MS fragmentation may be poor due to their amino acid compositions or the attachment of a bulky ICAT tag; 4) since protein disulfide bond reduction step was omitted from this redox ICAT study, it is possible that some of the free cysteines buried inside non-linearized protein domains may not be labeled efficiently by the bulky ICAT reagents; 5) redox-induced PTMs on non-cysteine residues such as phosphorylation, may occur non-uniformly in light and heavy ICAT-labeled peptides. Therefore quantification accuracy of ICAT may be affected; 6) some proteins bound to Trx1 with high affinity may still be reduced in the control animals, leading to similar reduction levels compared with Tg-Trx1 animals, regardless of the different Trx1 expression levels between the animal groups. Therefore, they may not be found in this ICAT difference-based study. Alternative approaches including "hooking" to C35S Trx1 mutant, may be used to identify some of these Trx1 targets (7, 8) .
Conclusions
In the present study, we performed a proteomic identification of Trx1 reduction target proteins from the hearts of cardiac-specific Tg-Trx1 mice. Using the comparative analysis of both iTRAQ and ICAT results, we were able to reveal many putative Trx1 reduction substrates, several of which were previously unknown. We identified several protein networks whose functions may be regulated by Trx1; including the creatine-phosphocreatine shuttle, the MPTP complex and the sarcomeric contractile apparatus. The results presented here suggest that in addition to its antioxidant function, Trx1 may be involved in the coordination of a wide array of cellular signaling pathways to maintain cardiac function. 
